{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-002373","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2026-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.950465+00:00","generated_at":"2026-05-15T05:41:06.645055+00:00","sec_items":["8.01","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"VolitionRx board approves 1-for-20 reverse stock split effective April 28, 2026","bullets":["Reverse stock split ratio set at 1-for-20, effective 12:01 a.m. ET on April 28, 2026.","No fractional shares; holders receive one whole share for any fractional interest.","Proportional adjustments to outstanding warrants, options, awards, and convertible notes.","Split follows shareholder approval at March 31, 2026 special meeting; tied to Lind Global financings."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-002373","json":"https://secwatch.observer/filing/0001477932-26-002373.json","markdown":"https://secwatch.observer/filing/0001477932-26-002373.md","text":"https://secwatch.observer/filing/0001477932-26-002373.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793226002373/0001477932-26-002373-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793226002373/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:41:06.645055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}